Sui, Yilun
Zou, Yaoyu
Xiao, Min
Fu, Jing
Li, Lu
Sun, Xiaoxi
Funding for this research was provided by:
Special Project for Clinical Research in the Health Industry of the Shanghai Municipal Health Commission (20224Y0218)
Special Project for Clinical Research in the Health Industry of the Shanghai Municipal Health Commission (20204Y0071)
National Natural Science Foundation of China (82200943)
Scientific Research Project of Shanghai Huangpu District (HLQ202319)
Article History
Received: 12 February 2025
Accepted: 18 February 2026
First Online: 25 February 2026
Declarations
:
: Ethics approval of the study was obtained from the ethics committee of assisted reproductive medicine in Shanghai Ji Ai Genetics and IVF Institute (approval number: JIAI E2022-011, study ID: 2022JIAI-10). All study designs will comply with the principles of the Declaration of Helsinki. All individuals will sign written informed consent forms before participating in the RCT. The trial was prospectively registered at on July 3rd, 2022 (NCT05447208, version 1) and verified annually according to the requirement of ClinicalTrials.gov (latest updated on Feb 7, 2025, Version 3).
: NA.
: The authors declare no competing interests.